| Vaccine and other immunizing agents | Birth | 1 mo | 2 mos | 4 mos | 6 mos | 9 mos | 12 mos | 15 mos | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
Respiratory syncytial virus  (RSV-mAb [Nirsevimab]) | 1 dose depending on maternal RSV vaccination status, See Notes | 1 dose (8 through 19 months), See Notes | |||||||||
| Hepatitis B (HepB) | 1st dose | ←2nd dose→ | ←3rd dose→ | ||||||||
| Rotavirus (RV) RV1 (2-dose series); RV5 (3-dose series) | 1st dose | 2nd dose | See Notes | ||||||||
| Diphtheria, tetanus, & acellular pertussis (DTaP: <7 yrs) | 1st dose | 2nd dose | 3rd dose | ←4th dose→ | |||||||
| Haemophilus influenzae type b (Hib) | 1st dose | 2nd dose | See Notes | ←3rd or 4th dose, See Notes→ | |||||||
| Pneumococcal conjugate (PCV15, PCV20) | 1st dose | 2nd dose | 3rd dose | ←4th dose→ | |||||||
| Inactivated poliovirus (IPV) | 1st dose | 2nd dose | ←3rd dose→ | ||||||||
| COVID-19 (1vCOV-mRNA, 1vCOV-aPS) | See Notes | ||||||||||
| Influenza (IIV3, ccIIV3) | 1 or 2 doses annually | ||||||||||
| Influenza (LAIV3) | |||||||||||
| Measles, mumps, rubella (MMR) | See Notes | ←1st dose→ | |||||||||
| Varicella (VAR) | ←1st dose→ | ||||||||||
| Hepatitis A (HepA) | (See Notes) | ←2-dose series, See Notes→ | |||||||||
| Tetanus, diphtheria, & acellular pertussis (Tdap: ≥7 yrs) | |||||||||||
| Human papillomavirus (HPV) | |||||||||||
| Meningococcal (MenACWY-CRM ≥2 mos, MenACWY-TT ≥2years) | See Notes | ||||||||||
| Meningococcal B (MenB-4C, MenB-FHbp) | |||||||||||
| Respiratory syncytial virus vaccine (RSV [Abrysvo]) | |||||||||||
| Dengue (DEN4CYD: 9-16 yrs) | |||||||||||
| Mpox | |||||||||||